KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $5.03.

  • Emergent BioSolutions' Times Interest Earned fell 3523.56% to $5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.99, marking a year-over-year increase of 20867.59%. This contributed to the annual value of -$1.53 for FY2024, which is 8147.39% up from last year.
  • Per Emergent BioSolutions' latest filing, its Times Interest Earned stood at $5.03 for Q3 2025, which was down 3523.56% from $0.11 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Times Interest Earned registered a high of $31.87 during Q4 2021, and its lowest value of -$12.29 during Q3 2023.
  • For the 5-year period, Emergent BioSolutions' Times Interest Earned averaged around -$0.24, with its median value being -$0.64 (2024).
  • In the last 5 years, Emergent BioSolutions' Times Interest Earned soared by 90417.85% in 2021 and then plummeted by 128486.82% in 2022.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Times Interest Earned stood at $31.87 in 2021, then crashed by 113.56% to -$4.32 in 2022, then surged by 53.28% to -$2.02 in 2023, then soared by 68.2% to -$0.64 in 2024, then soared by 884.07% to $5.03 in 2025.
  • Its Times Interest Earned stands at $5.03 for Q3 2025, versus $0.11 for Q2 2025 and $3.39 for Q1 2025.